Explore 3 Stock Ideas & Industry Insights Download Free Report

Modular Medical Inc

Company price
1.7 USD 0.37 ( 27.82%)
Last update at 2026-11-09T15:43:00Z
VOLUME
68358
Market Cap
19.64M

Momentum Score

…

Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It offers Pivot product, a tubeless insulin delivery system that integrates the set into a true tubeless patch. Modular Medical, Inc. is headquartered in San Diego, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.31
Low
1.71
High
52 Week Price Range
1.72
Low
23.10
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Publicly available information on Modular Medical Inc (NASDAQ: MODD) is limited, with filings providing few specifics about product lines, market focus, or operating history. The company's long-term outlook therefore depends on successful development and commercialization of its offerings and potential strategic partnerships, which may attract investors seeking early-stage exposure in healthcare.
Material risks include uncertain product and clinical development outcomes, regulatory approval timing, likely need for additional capital with potential dilution, limited stock liquidity, and strong competition from established medical device and healthcare firms.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.33
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
0.03
ROE
-247.94%
Net Debt
-6.55M
ROCE
-212.67%
Diluted EPS TTM
-9.85

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Income before tax -28.24M -18.82M -17.47M -13.88M -18.63M
Net income -28.24M -18.82M -17.47M -13.88M -18.63M
Selling general administrative 7.59M 4.35M 4.65M 4.82M 7.20M
Selling and marketing expenses - - 0.45M - -
Gross profit -1.67M -1.43M -0.77M - -
Reconciled depreciation 1.67M 1.06M 0.43M 0.15M 0.20M
Ebit -27.56M -18.82M -17.47M -13.88M -14.93M
Ebitda -25.89M -17.76M -17.04M -13.72M -14.36M
Depreciation and amortization 1.67M 1.06M 0.43M 0.15M 0.57M
Operating income -27.56M -19.05M -17.53M -13.88M -14.93M
Other operating expenses 27.56M 19.05M 17.53M 13.88M 14.93M
Interest expense - - - -0.97M 2.75M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Net interest income - - - 0.00M -2.75M
Income tax expense 0.00M 0.00M 0.00M 0.00M 0.00M
Total revenue 0.00M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 25.89M 19.05M 17.53M 13.88M 14.93M
Cost of revenue 1.67M 1.43M 0.77M - -
Total other income expense net -0.68M 0.23M 0.06M 0.00M -3.70M
Net income from continuing ops -28.24M -18.82M -17.47M -13.88M -18.63M
Net income applicable to common shares - - - -13.88M -18.63M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total assets 14.83M 18.73M 13.81M 7.25M 9.85M
Other current assets 0.58M 0.35M 0.32M 0.15M 0.00M
Total liab 1.87M 1.66M 2.27M 2.17M 1.01M
Total stockholder equity 12.96M 17.08M 11.54M 5.08M 8.84M
Other current liab 0.49M 0.50M 0.28M 338.70M 0.52M
Common stock 0.01M 0.05M 0.03M 0.01M 0.01M
Capital stock 0.01M 0.05M 0.03M 0.01M 0.01M
Retained earnings -113.00M -84.75M -65.93M -48.46M -34.58M
Other assets - - - - 0.10M
Cash 6.94M 13.10M 9.23M 3.80M 9.08M
Total current liabilities 1.87M 1.26M 1.46M 0.98M 0.97M
Current deferred revenue - - - -338.36M -
Net debt -6.55M -12.28M -8.04M -2.25M -8.89M
Short term debt 0.39M 0.42M 0.37M 0.36M 0.14M
Short long term debt total 0.39M 0.82M 1.19M 1.55M 0.18M
Other stockholder equity 125.95M 101.78M 77.43M 53.52M 43.41M
Property plant equipment - - - 3.20M 0.36M
Total current assets 7.54M 13.52M 9.70M 4.05M 9.39M
Net tangible assets - - - 5.08M 8.84M
Net receivables 0.02M 0.07M 0.15M - -
Accounts payable 0.99M 0.34M 0.80M 0.29M 0.30M
Non currrent assets other 0.06M - - - 0.10M
Non current assets total 7.29M 5.22M 4.11M 3.20M 0.46M
Capital lease obligations 0.39M 0.82M 1.19M 1.55M 0.18M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Investments - -2.49M -1.70M -1.64M -0.05M
Change to liabilities - - - -0.20M 0.35M
Total cashflows from investing activities -3.93M -2.49M -1.70M -1.64M -0.05M
Net borrowings 0.00M 0.00M - - 4.14M
Total cash from financing activities 21.53M 22.08M 21.09M 7.37M 17.92M
Change to operating activities - - - -0.01M 0.73M
Net income -28.24M -18.82M -17.47M -13.88M -18.63M
Change in cash -6.15M 3.86M 5.43M -5.28M 7.61M
Begin period cash flow 13.10M 9.23M 3.80M 9.08M 1.47M
End period cash flow 6.94M 13.10M 9.23M 3.80M 9.08M
Total cash from operating activities -23.75M -15.72M -13.95M -11.01M -10.26M
Issuance of capital stock 17.55M 20.82M 20.34M 7.37M 13.79M
Depreciation 1.67M 1.06M 0.77M 0.15M 0.20M
Other cashflows from financing activities 21.53M 1.25M 0.74M -1.64M 6.24M
Change to netincome - - - 2.73M 5.26M
Capital expenditures 3.93M 2.49M 1.70M 1.64M 0.05M
Change in working capital 0.19M -0.39M -0.09M -0.21M 0.42M
Stock based compensation 1.78M 2.38M 2.70M 2.72M 4.03M
Other non cash items 0.84M 0.05M 0.14M 0.20M 3.72M
Free cash flow -27.68M -18.21M -15.65M -12.65M -10.31M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
MODD
Modular Medical Inc
0.37
27.82%
1.70 - - - 1.95 -3.21
ABT
Abbott Laboratories
-0.36
0.33%
109.56 25.97 17.24 3.57 3.20 16.75
MDT
Medtronic PLC
-0.14
0.14%
101.66 26.60 15.87 3.35 2.08 14.12
SYK
Stryker Corporation
-0.84
0.26%
325.03 29.23 16.86 4.18 4.51 17.16
SEMHF
Siemens Healthineers AG
-2.15
4.12%
49.85 39.57 21.32 3.01 3.29 16.92

Profile*

Modular Medical Inc

Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It offers Pivot product, a tubeless insulin delivery system that integrates the set into a true tubeless patch. Modular Medical, Inc. is headquartered in San Diego, California.

10740 Thornmint Road, San Diego, CA, United States, 92127

858 800 3500

51

Name Title Year Born
Mr. Paul M. DiPerna Founder, Pres, CFO, Sec., Treasurer & Chairman 1959
Mr. James E. Besser Chief Exec. Officer 1976
Mr. Kevin Schmid Chief Operating Officer 1959
Marc Goldman Head of Engineering NA
Mr. Paul M. DiPerna Founder, Chairman, President, CFO & Treasurer 1959
Mr. James E. Besser Chief Executive Officer 1976
Mr. James E. Besser Chief Executive Officer 1977
Mr. David Bosshard Head of International Operations NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…